D-4418

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 581085

CAS#: 257892-34-5

Description: D-4418, is PDE4 inhibitors has been in development as a novel anti-inflammatory therapy with asthma and chronic obstructive pulmonary disease (COPD) being primary indications.


Price and Availability

Size
Price

Size
Price

Size
Price

D-4418 is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to sales@medkoo.com to inquire quote.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 581085
Name: D-4418
CAS#: 257892-34-5
Chemical Formula: C16H11Cl2N3O2
Exact Mass: 347.0228
Molecular Weight: 348.18
Elemental Analysis: C, 55.19; H, 3.18; Cl, 20.36; N, 12.07; O, 9.19


Synonym: D-4418; D4418; UNII-24A61J8R9E;

IUPAC/Chemical Name: 5-Quinolinecarboxamide, N-(2,5-dichloro-3-pyridinyl)-8-methoxy-

InChi Key: FSDOTMQXIKBFKJ-UHFFFAOYSA-N

InChi Code: InChI=1S/C16H11Cl2N3O2/c1-23-13-5-4-11(10-3-2-6-19-14(10)13)16(22)21-12-7-9(17)8-20-15(12)18/h2-8H,1H3,(H,21,22)

SMILES Code: O=C(C1=C2C=CC=NC2=C(OC)C=C1)NC3=CC(Cl)=CN=C3Cl


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
293490


References

1: Crocker IC, Townley RG. Therapeutic potential of phosphodiesterase 4 inhibitors in allergic diseases. Drugs Today (Barc). 1999 Jul;35(7):519-35. PubMed PMID: 12973397.

2: Giembycz MA. Can the anti-inflammatory potential of PDE4 inhibitors be realized: guarded optimism or wishful thinking? Br J Pharmacol. 2008 Oct;155(3):288-90. doi: 10.1038/bjp.2008.297. Epub 2008 Jul 28. PubMed PMID: 18660832; PubMed Central PMCID: PMC2567889.